Predictive value of tumor genetic alteration profiling for chemotherapy and EGFR-TKI treatment in advanced NSCLC.

Jiang, Wei; Zeng, Aiping; Ning, Ruiling; Zhao, Wenhua; Su, Cuiyun; Wang, Huilin; Zhou, Shaozhang; Yu, Qitao.

Affiliation

Jiang W; Department of Respiratory Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Zeng A; Department of Respiratory Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Ning R; Department of Respiratory Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Zhao W; Department of Respiratory Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Su C; Department of Respiratory Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Wang H; Department of Respiratory Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Zhou S; Department of Respiratory Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Yu Q; Department of Respiratory Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.

Oncol Lett ; 19(6): 3859-3870, 2020 Jun.

Article in En | MEDLINE | ID: mdl-32382334